These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11327838)

  • 1. Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p.
    Thual C; Bousset L; Komar AA; Walter S; Buchner J; Cullin C; Melki R
    Biochemistry; 2001 Feb; 40(6):1764-73. PubMed ID: 11327838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the prion Ure2p in protein fibrils assembled in vitro.
    Fay N; Redeker V; Savistchenko J; Dubois S; Bousset L; Melki R
    J Biol Chem; 2005 Nov; 280(44):37149-58. PubMed ID: 16131495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
    Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae.
    Bousset L; Belrhali H; Janin J; Melki R; Morera S
    Structure; 2001 Jan; 9(1):39-46. PubMed ID: 11342133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion domain initiation of amyloid formation in vitro from native Ure2p.
    Taylor KL; Cheng N; Williams RW; Steven AC; Wickner RB
    Science; 1999 Feb; 283(5406):1339-43. PubMed ID: 10037606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2.
    Thual C; Komar AA; Bousset L; Fernandez-Bellot E; Cullin C; Melki R
    J Biol Chem; 1999 May; 274(19):13666-74. PubMed ID: 10224139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen/deuterium exchange mass spectrometric analysis of conformational changes accompanying the assembly of the yeast prion Ure2p into protein fibrils.
    Redeker V; Halgand F; Le Caer JP; Bousset L; Laprévote O; Melki R
    J Mol Biol; 2007 Jun; 369(4):1113-25. PubMed ID: 17482207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and assembly properties of the N-terminal domain of the prion Ure2p in isolation and in its natural context.
    Bousset L; Bonnefoy J; Sourigues Y; Wien F; Melki R
    PLoS One; 2010 Mar; 5(3):e9760. PubMed ID: 20339590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide bond formation significantly accelerates the assembly of Ure2p fibrils because of the proximity of a potential amyloid stretch.
    Fei L; Perrett S
    J Biol Chem; 2009 Apr; 284(17):11134-41. PubMed ID: 19258323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folding of the yeast prion protein Ure2: kinetic evidence for folding and unfolding intermediates.
    Galani D; Fersht AR; Perrett S
    J Mol Biol; 2002 Jan; 315(2):213-27. PubMed ID: 11779240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
    Catharino S; Buchner J; Walter S
    Biol Chem; 2005 Jul; 386(7):633-41. PubMed ID: 16207084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equilibrium folding properties of the yeast prion protein determinant Ure2.
    Perrett S; Freeman SJ; Butler PJ; Fersht AR
    J Mol Biol; 1999 Jul; 290(1):331-45. PubMed ID: 10388576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells.
    Masison DC; Wickner RB
    Science; 1995 Oct; 270(5233):93-5. PubMed ID: 7569955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and assembly properties of the yeast prion Ure2p.
    Bousset L; Thual C; Belrhali H; Morera S; Melki R
    C R Biol; 2002 Jan; 325(1):3-8. PubMed ID: 11862619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction domains of Ure2p, a prion-like protein of yeast.
    Fernandez-Bellot E; Guillemet E; Baudin-Baillieu A; Gaumer S; Komar AA; Cullin C
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):403-7. PubMed ID: 10024516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.
    Wickner RB
    Science; 1994 Apr; 264(5158):566-9. PubMed ID: 7909170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of distinct [URE3] yeast prion strains.
    Schlumpberger M; Prusiner SB; Herskowitz I
    Mol Cell Biol; 2001 Oct; 21(20):7035-46. PubMed ID: 11564886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between stability of folding intermediates and amyloid formation for the yeast prion Ure2p: a quantitative analysis of the effects of pH and buffer system.
    Zhu L; Zhang XJ; Wang LY; Zhou JM; Perrett S
    J Mol Biol; 2003 Apr; 328(1):235-54. PubMed ID: 12684011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.
    Edskes HK; Gray VT; Wickner RB
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1498-503. PubMed ID: 9990052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.